Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cytopenia × Emapalumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Cytopenia 1 Bone Marrow Failure Disorders 1 Anemia, Aplastic 1

Interventions

thymoglobulin 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 Pluvicto 1 Peripheral Blood Stem Cell Transplantation 1 Metformin 1 IDO-1 inhibitor LY3381916 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Emapalumab 1 Cyclophosphamide 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06430788 2025-12-17

A Study of Emapalumab for Pediatric Aplastic Anemia

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting

Classical hematology

Bone Marrow Failure Disorders, Cytopenia, Anemia, Aplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡